Fensolvi
Payments companies reported to CMS as associated with Fensolvi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fensolvi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fensolvi
These are the largest totals companies reported as associated with Fensolvi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joshua Yang | Orlando, FL | Pediatric Endocrinology | $45,831.22 |
| Bradley Miller | Minneapolis, MN | Pediatric Endocrinology | $31,085.17 |
| Karen Klein | San Diego, CA | Pediatric Endocrinology | $29,960.11 |
| Craig Alter | Philadelphia, PA | Pediatric Endocrinology | $23,436.53 |
| Lawrence Silverman | Morristown, NJ | Pediatric Endocrinology | $14,445.07 |
| Marcela Vargas Trujillo | San Diego, CA | Pediatric Endocrinology | $13,285.55 |
| Reema Habiby | Chicago, IL | Pediatric Endocrinology | $11,191.97 |
| Kristin Sabanosh | Sparta, NJ | Pediatrics (Nurse Practitioner) | $8,698.92 |
| Jadranka Popovic | Pittsburgh, PA | Pediatric Endocrinology | $6,626.79 |
| Mary Bertossi | Atlanta, GA | Pediatrics (Nurse Practitioner) | $6,372.27 |
Prescribed Fensolvi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.